EvidentIQ welcomes DACIMA Software into their end-to-end eClinical solutions group.

Today, EvidentIQ, a leading provider of end-to-end eClinical and Patient Insights solutions, announced the acquisition of DACIMA Software, a Canadian clinical software company founded in 2006.

EvidentIQ, based in Hamburg, is a leading clinical data science group, offering an end-to-end platform of state-of-the art eClinical solutions (eConsent, EDC, CTMS, eCOA,) that helps its customers with the planning and execution of both hybrid/decentralized and traditional clinical trials. Thanks to its global patient platform Carenity, the group combines their technology with a direct access to real-world patient insights, enabling them to support sponsors and CROs with innovative offerings such as eFeasibility, eRecruitment and Real-World Evidence data collection and analysis

Dacima, based in Montreal, offers a cutting edge flexible Electronic Data Capture (EDC) platform for the design and management of clinical trials, observational studies, patient registries, clinical databases, electronic Patient Reported Outcomes (ePRO), eDiaries and eConsent. It’s advanced eClinical capabilities will enrich EvidentIQ Group product lineup with software solutions for electronic Clinical Outcome Assessment (eCOA) and eConsent.  The company has been founded by experts in epidemiology, medical research and information technology who understand the needs of users and requirements of eClinical software for the healthcare sector.

By integrating EvidentIQ’s patient community, data science solutions and eClinical backbone with Dacima’s products, the group will provide the technology for hybrid and decentralized clinical trials (DCT) as a one-stop-shop on a global basis. This acquisition will help EvidentIQ to build a complete offer that covers every step in the value chain of clinical research and development, enhance their unique end-to-end solutions to help the life sciences industry run innovative patient-centric clinical studies and optimize clinical research.

Über die EvidentIQ Group GmbH

EvidentIQ is a next generation technology-amplified data science group championing new standards in value creation and innovation driven relevance for customers. The EvidentIQ offering brings a pioneering end-to-end eClinical solution that meets increasing customer demand across clinical operations and clinical data management needs, with a suite of applications within a single integrated cloud platform. By combining its platform with a broad data science service portfolio including patient recruitment, patient engagement media and RWE solutions, EvidentIQ significantly aids customers in optimizing HTA submissions, pricing and reimbursement needs. EvidentIQ has become a pillar of Real-World Evidence and data science pioneering in digitalization of clinical research and offering state-of-the art eClinical solutions (eConsent, EDC, CTMS, eCOA).

EvidentIQ supports 15 of the top 20 pharma companies through novel RWE solutions and 150+ SMB customers in over 20 countries, including the US, Germany, France, the UK, Italy, Japan and China.

Firmenkontakt und Herausgeber der Meldung:

EvidentIQ Group GmbH
Rathausmarkt 5
20095 Hamburg
Telefon: +49 (89) 4522775000
Telefax: +49 (89) 4522775900
https://evidentiq.com

Ansprechpartner:
Andreas Weber
CEO
E-Mail: andreas.weber@evidentiq.com
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel